• Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • Despite encouraging declines in maternal mortality over the last two decades, women in resource-poor areas of the world still bear a disproportionate burden. Worldwide, around 10 million women develop preeclampsia each year and about 10-25% of cases in developing countries lead to death. Women in developing countries bear a disproportionate burden - they are seven times more likely to experience preeclampsia than a woman in developed countries.


    Preeclampsia is a disorder defined clinically by hypertension and proteinuria, with or without pathologic edema, and can progress to eclampsia. Eclampsia is a serious condition that can cause seizures, kidney and liver damage, and death. There are currently no ways to accurately predict preeclampsia, but urinalysis and blood pressure readings can be used to diagnose the disorder. In place where resources are scarce, urine dipsticks are used instead of urinalysis, but results are not always reliable. 

    In response to these problems, Maternova partnered with HOPE Foundation Bangladesh to conduct a study looking at the feasibility of a novel urinalysis technology powered by an Android device and cuboid light box called the uChek device. Funded by Merck for Mothers, the study took place at a rural hospital in Ramu, Cox’s Bazar, Bangladesh, near the country’s border with Myanmar, and aimed to look at whether midwives could effectively use the device to conduct enhanced urinalysis.  At the beginning of the study, half of the midwives found the device to be “daunting”, but at the end of the study, all of them agreed that the uChek provided faster and more reliable results. Furthermore, these results showed that these smartphone enabled medical devices could be incorporated with minimal additional training or resources - important considerations in places without a lot of resources. 

    Devices such as the uChek can prove to be invaluable in early diagnoses of preeclampsia, which in turn can mean many saved lives. Early diagnosis can allow for better planning and preparation; for example, if warning signs are detected at 20 weeks gestation, the device can be programmed to prompt the provider to prescribe the appropriate supplements, frequent antenatal checks, and to plan with an obstetrician for special preparations during and post-delivery. This study adds to the growing body of evidence showing that smartphone technology is becoming an increasingly important tool for medical diagnosis in remote areas.

     

    blog by Vivian Shih

    Leave a comment

    Comments will be approved before showing up.


    Also in The Maternova Blog

    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)
    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)

    May 25, 2026 1 min read

    High quality ISO 13485 and CE-marked Non-pneumatic anti shock garments (NASG) produced by Maternova for use by midwives and obstetricians all over the world to save lives threatened by postpartum hemorrhage.  Our NASGS adhere to the highest standards and are trusted by hundreds of clinicians. 

    Read More
    A $.03 pill that could prevent maternal deaths; Part 5
    A $.03 pill that could prevent maternal deaths; Part 5

    May 25, 2026 2 min read

    Read More
    A $.03 pill that could save maternal lives: low dose aspirin.... Part 3
    A $.03 pill that could save maternal lives: low dose aspirin.... Part 3

    May 25, 2026 2 min read

    A 2025 study at a Federally Qualified Health Center (FQHC) serving a socially vulnerable population proved that with implementation of a universal low dose aspirin protocol, adherence jumped from 8.7% to 75%.

    Read More